{"id":63623,"date":"2015-10-26T02:37:55","date_gmt":"2015-10-26T07:37:55","guid":{"rendered":"https:\/\/canadianinquirer.net\/v1\/?p=63623"},"modified":"2015-10-26T02:37:56","modified_gmt":"2015-10-26T07:37:56","slug":"china-makes-worlds-1st-3d-blood-vessel-bio-printer","status":"publish","type":"post","link":"https:\/\/canadianinquirer.net\/v1\/2015\/10\/26\/china-makes-worlds-1st-3d-blood-vessel-bio-printer\/","title":{"rendered":"China makes world&#8217;s 1st 3D blood vessel bio-printer"},"content":{"rendered":"<p>CHENGDU &#8211; A Chinese biotechnological company announced on Sunday it has developed the world&#8217;s first 3D blood vessel bio-printer, which makes it possible to produce personalized functional organs.<\/p>\n<p>Sichuan Revotek Co., Ltd. based in Chengdu, capital of southwest China&#8217;s Sichuan Province, said the significant breakthrough has been achieved through its self-developed stem cell bio-ink technology, 3D bio-printer and cloud computing platform.<\/p>\n<p>&#8220;The creative breakthrough in the 3D blood vessel bio-printing means we have mastered the stem cell-based 3D bio-printing technology,&#8221; said Yang Keng, chairman of Sichuan Languang Development Co., Ltd. Revotek is a subsidiary of Sichuan Languang.<\/p>\n<p>Blood vessels that transport nutrients to organs are indispensable elements when creating any organs, according to James Kang, an expert who led the program.<\/p>\n<p>Kang&#8217;s team has created a novel type of bio-ink &#8211; \u00a0&#8220;Biosynsphere&#8221;, whose primary goal is the personalized stem cell bio-printing to pave the way for organ regeneration.<\/p>\n<p>&#8220;We have successfully realized the blood vessel regeneration by relying on the 3D bio-printer, the biosynsphere technology and the data model based on cloud computing,&#8221; he said.<\/p>\n<p><span style=\"font-family: Verdana, Arial, Helvetica, sans-serif;font-size: small\">The company said it is willing to absorb more talent and seek international cooperation for the application of the achievements.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>CHENGDU &#8211; A Chinese biotechnological company announced on Sunday it has developed the world&#8217;s first 3D blood vessel bio-printer, which &hellip;<\/p>\n","protected":false},"author":44,"featured_media":63624,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[9230],"class_list":["post-63623","post","type-post","status-publish","format-standard","has-post-thumbnail","category-technology","tag-uploads","mauthors-philippine-news-agency"],"_links":{"self":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/63623","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/users\/44"}],"replies":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/comments?post=63623"}],"version-history":[{"count":0,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/posts\/63623\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media\/63624"}],"wp:attachment":[{"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/media?parent=63623"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/categories?post=63623"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadianinquirer.net\/v1\/wp-json\/wp\/v2\/tags?post=63623"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}